Amplitude Surgical – 2017-18 Annual Results

Sales of over €100 Million, up +8% Like-for-Like, and Solid EBITDA Growth of +17% - Seite 2

  € thousands - IFRS     2017-18      

2016-17

      Δ Sales     100,336       93,356       +7.5% Gross margin     75,743       70,519       +7.4% as a % of sales     75.5%       75.6%       - Sales & Marketing costs     39,933       38,626       +3.4% General & Administrative costs     10,958       9,321       +17.6 Research & Development costs     6,784       7,072       -4.1% EBITDA     18,068       15,500       +16.6% as a % of sales     18.0%       16.6%         Core operating profit     2,264       17         Net non-core operating expenses     -2,503       -1,063         Operating profit/loss     -239       -1,046         Financial profit/loss     -8,129       -8,510         Attributable net profit/loss     -9,446       -12,052         Net financial debt     93,697       80,043         Net cash position     29,338       41,610          

EBITDA of €18.1 million and +140 bp improvement in the margin to 18%, despite the negative currency effect